文献速递胸部肿瘤

间皮瘤风险评分:恶性胸膜间皮瘤治疗前临床分子预后新算法

Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma.
PubMed 文献 · J Thorac Oncol · 2021-07-06

本研究基于2007-2014年前瞻性收集的接受胸膜外全肺切除(EPP)或胸膜剥脱术(PD)的恶性胸膜间皮瘤患者数据,整合间皮瘤预后检测(MPT)、分子亚型、肿瘤体积(TV)和中性粒细胞与淋巴细胞比值(NLR)构建预后模型。在EPP队列(N=191)和PD队列(N=193)中分别建立三组风险模型,预测准确性(c-index)分别为0.644和0.641,优于已发表模型和病理分期。该模型利用微创活检、影像和血液检测的治疗前参数,可评估不同手术类型的预期结局并改善临床试验分层。

要点

  • MPT、分子亚型、TV和NLR在EPP患者中均为独立预后因素。
  • PD队列中MPT不良风险合并TV>200 cm3者死亡风险为其他亚组的2.94倍(95%CI 1.70-5.09,p<0.001)。
  • 新模型预测准确性(c=0.644/0.641)优于已发表模型(c≤0.584/0.575)和病理分期(c=0.554/0.571)。

核心结论

  • 基于治疗前临床分子参数的新模型可提高恶性胸膜间皮瘤的预后分层准确性,优于现有模型和病理分期。

研究设计与样本

  • 前瞻性收集2007-2014年接受EPP(N=191)或PD(N=193)的恶性胸膜间皮瘤患者的肿瘤标本和临床数据。
  • 通过实时定量PCR检测MPT和claudin-15与vimentin表达比值,术前影像评估肿瘤体积。
  • 基于Cox模型组合不良因素建立风险分组,用Harrell's c-index评估预测准确性。

主要发现

  • 在EPP队列中,MPT、分子亚型、TV和NLR均为独立预后因素,最终三组模型c=0.644。
  • 在PD队列中,MPT不良风险合并TV>200 cm3者风险为其他亚组的2.94倍(95%CI 1.70-5.09,p<0.001),调整分子亚型、NLR、体能状态和血清白蛋白后仍显著,最终三组模型c=0.641。
  • EPP和PD模型的预测准确性高于已发表模型(c≤0.584和c≤0.575)及病理分期(c=0.554和c=0.571)。

关键数值与推荐

  • EPP模型最终三组模型c-index为0.644。
  • PD模型最终三组模型c-index为0.641。
  • PD队列中MPT不良风险合并TV>200 cm3的风险比HR=2.94(95%CI 1.70-5.09,p<0.001)。

临床怎么用

  • 利用微创活检、影像和血液检测获得的治疗前参数,评估新诊断患者接受EPP或PD的预期结局。
  • 该模型可改善临床试验中的患者分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Prognostic models for malignant pleural mesothelioma have been limited to demographics, symptoms, and laboratory values. We hypothesize higher accuracy using both tumor and patient characteristics. The mesothelioma prognostic test (MPT) and molecular subtype based on claudin-15-to-vimentin expression ratio are molecular signatures associated with survival. Tumor volume (TV) has improved performance compared with clinical staging, whereas neutrophil-to-lymphocyte ratio (NLR) is prognostic for malignant pleural mesothelioma. METHODS: Tumor specimens and clinical data were collected prospectively from patients who underwent extrapleural pneumonectomy (EPP) or pleurectomy and decortication (PD) during 2007 to 2014. MPT and claudin-15-to-vimentin ratio were determined by real-time quantitative polymerase chain reaction, whereas TV was assessed from preoperative scans. Risk groups were derived from combinations of adverse factors on the basis of the Cox model. Predictive accuracy was assessed using Harrell's c-index. RESULTS: MPT, molecular subtype, TV, and NLR were independently prognostic in patients with EPP (N = 191), suggesting equal weighting in a final three-group model (c = 0.644). In the PD cohort (N = 193), MPT poor risk combined with TV greater than 200 cm3 was associated with triple the risk compared with other subgroups (hazard ratio = 2.94, 95% confidence interval: 1.70-5.09, p < 0.001) persisting when adjusted for molecular subtype, NLR, performance status, and serum albumin to yield a final three-group model (c = 0.641). The EPP and PD models achieved higher accuracy than published models (c ≤ 0.584, c ≤ 0.575) and pathologic staging (c = 0.554, c = 0.571). CONCLUSIONS: The novel models use pretreatment parameters obtained from minimally invasive biopsy, imaging, and blood tests to evaluate the expected outcome of each type of surgery in newly diagnosed patients and improve stratification on clinical trials.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Yeap BY, De Rienzo A, Gill RR, et al. Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma. J Thorac Oncol. 2021. PMID: 34242791. doi:10.1016/j.jtho.2021.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。